Neogen Corporation short interest in 2018
In 2018, Neogen Corporation's disclosed short interest ran from 3.67% of shares outstanding on 28 Feb 2018 to 3.86% on 31 Dec 2018, a change of +0.19 percentage points. The year's high was 4.83% on 14 Sep 2018 and its low 3.67% on 28 Feb 2018, averaging 4.25% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.99 days on 15 Aug 2018. Full history: Neogen Corporation.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2018 in figures
- Start of year
- 3.67% (28 Feb 2018)
- End of year
- 3.86% (31 Dec 2018)
- Change
- +0.19 pp
- High
- 4.83% (14 Sep 2018)
- Low
- 3.67% (28 Feb 2018)
- Average
- 4.25%
- Highest days to cover
- 16.99 (15 Aug 2018)
- SEC filings marked
- 10
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Feb 2018 | 3.67% | 11.56 | results (8-K), 10-Q filed |
| 15 Mar 2018 | 3.93% | 12.35 | |
| 29 Mar 2018 | 4.27% | 7.29 | results (8-K), 10-Q filed |
| 13 Apr 2018 | 4.48% | 12.71 | |
| 30 Apr 2018 | 4.38% | 14.57 | |
| 15 May 2018 | 4.18% | 13.27 | |
| 31 May 2018 | 3.88% | 8.96 | |
| 15 Jun 2018 | 4.43% | 9.17 | |
| 29 Jun 2018 | 4.55% | 11.48 | |
| 13 Jul 2018 | 4.52% | 15.51 | |
| 31 Jul 2018 | 4.67% | 10.68 | results (8-K), 10-K filed |
| 15 Aug 2018 | 4.51% | 16.99 | |
| 31 Aug 2018 | 4.45% | 12.73 | |
| 14 Sep 2018 | 4.83% | 16.92 | |
| 28 Sep 2018 | 4.65% | 4.35 | results (8-K) |
| 15 Oct 2018 | 3.88% | 5.17 | 10-Q filed |
| 31 Oct 2018 | 4.10% | 8.03 | |
| 15 Nov 2018 | 4.21% | 12.09 | |
| 30 Nov 2018 | 3.84% | 9.83 | |
| 14 Dec 2018 | 3.86% | 7.86 | |
| 31 Dec 2018 | 3.86% | 6.70 | results (8-K), 10-Q filed |
See also: Neogen Corporation's full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.